Delivery Order SPE2DB22D2005-SPE2DB24FJRR2

Award Date 8/21/24
Potential Completion Date 8/22/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical medication. The contract has a ceiling value of $49,066.84 and an ultimate completion date of October 22, 2024. This delivery order is a component of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml pens, a specialty medication, to support military healthcare programs. The contract has a ceiling value of $12,347.50 and a period of performance through May 31, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml pens, with a total ceiling value of $20,513.52 and a period of performance through December 2, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pens. The contract has a ceiling value of $11,497.38 and an ultimate completion date of September 12, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen, through its extensive supply chain network, will provide these critical prescription medications to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product, to support military healthcare programs. The contract has a ceiling value of $10,669.97 and runs through November 12, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the procurement of Dupixent 300 mg/2 mL pens, a specialty medication. The firm-fixed-price contract has a ceiling value of $7,368 and a completion date of June 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Dupixent 300 mg/2 ml pens, a specialty medication. The contract has a ceiling value of $6,609.40 and a completion date of September 6, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical valued at up to $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pens. The contract has a firm fixed price and a ceiling value of $12,256.72, with a period of performance through May 21, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Dupixent 300 mg/2 ml pens, with a ceiling value of $15,149.62 and a completion date of April 30, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,464.32 firm fixed-price contract is for the supply of Dupixent 300 mg/2 ml pens to support military healthcare programs. The contract has a ceiling value of $5,464.32 and a period of performance ending on November 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJRR2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Dupixent 300 mg/2 ml pens. The contract has a ceiling value of $13,633.82 and an ultimate completion date of August 22, 2024. As the contract is a delivery order, it is likely part of a larger Indefinite Delivery Contract (IDC) vehicle held by AmerisourceBergen with the DLA. The contract is for the delivery of a specialty pharmaceutical product to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract does not have a set-aside designation.

Generated 11/20/24, 9:22 AM